SCHEMBL6132089

SCHEMBL6132089

COc1cccc(-c2[nH]ncc2-c2cccc([N+](=O)[O-])c2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.54
ADORA2A P29274 1/20 0.53
TGFBR1 P36897 1/20 0.52
LMNA P02545 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
NPC1 O15118 1/20 0.51
CASP3 P42574 1/20 0.51
RAB9A P51151 1/20 0.51
KEAP1 Q14145 1/20 0.50
NFE2L2 Q16236 1/20 0.50
KMT2A Q03164 6/20 0.48
HTR1A P08908 2/20 0.47
HTR7 P34969 2/20 0.47
HTR2B P41595 2/20 0.47
HTR3A P46098 2/20 0.47
MAOB P27338 1/20 0.47
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
HTR6 P50406 1/20 0.47
MEN1 O00255 5/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30469306 0.81 MAOB (0.60) ADORA2ALMNASMN1; SMN2NPC1CASP3
SCHEMBL20557970 0.81 MAOB (0.60) ADORA2ALMNASMN1; SMN2NPC1CASP3
SCHEMBL6132077 0.80 TGFBR1 (0.56) TGFBR1LMNAKMT2AHTR1AHTR7
SCHEMBL6132047 0.75 KMT2A (0.57) TGFBR1LMNAKMT2AHTR1AHTR7
SCHEMBL24209382 0.75 LMNA (0.56) TDP1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL30059246 0.75 LMNA (0.61) LMNANPC1RAB9AKEAP1NFE2L2
SCHEMBL28218708 0.75 LMNA (0.61) LMNANPC1RAB9AKEAP1NFE2L2
SCHEMBL515302 0.75 LMNA (0.61) LMNANPC1RAB9AKEAP1NFE2L2
SCHEMBL7108951 0.74 MAOB (0.56) TDP1ADORA2ALMNASMN1; SMN2NPC1
SCHEMBL30009634 0.74 NFE2L2 (0.51) TDP1RAB9AKEAP1NFE2L2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435957-A4 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMA (US) 2005-04-13 EP claimed
EP-1435957-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES Vertex Pharmaceuticals Incorporated (US) 2004-07-14 EP claimed
WO-2002088078-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO claimed